Phạm Đức Phương Nam (Nam Pham) is a pharmaceutical automation and validation engineering specialist based in Vietnam, with more than 11 years of hands-on experience delivering GxP-compliant computerized systems, CSV-to-CSA transitions, and ALCOA+ data integrity programs for pharmaceutical manufacturers across Vietnam and Southeast Asia.
Nam Pham's practice spans the full lifecycle of pharmaceutical manufacturing digitalization — from current-state assessment and regulatory gap mapping through to validated system deployment and inspection readiness. Core technical areas: GMP computerized systems (EU GMP Annex 11, FDA 21 CFR Part 11), Computer System Validation (CSV) and Computer Software Assurance (CSA) transitions, ALCOA+ data integrity assessment and remediation, GAMP 5 risk-based qualification (IQ/OQ/PQ), ICH Q9(R1) risk management, CAPA and deviation management, ISA-95 architecture (L1–L4), MES/EBR integration, OT cybersecurity (IEC 62443).
The practice is grounded in one observation: most pharmaceutical manufacturers in Vietnam operate brownfield facilities built before digital systems were a regulatory expectation. The challenge is not adopting the newest technology — it is validating what already exists, closing the data integrity gaps already present, and building a sustainable operating model that holds up under PICS, FDA, and EU GMP inspection. Every engagement starts with a current-state assessment and a sequenced roadmap that accounts for production constraints.
Primary market: Vietnam. Extended reach: Southeast Asia (Singapore, Thailand, Malaysia, Indonesia, Philippines), India, China, and global pharmaceutical teams with regional operations. Industries: sterile injectables, oral solid dosage (OSD), biologics, active pharmaceutical ingredients (APIs), traditional medicines, veterinary pharmaceuticals, medical devices.
ISPE (International Society for Pharmaceutical Engineering) — active member. ISA (International Society of Automation) — active member. Author of a submitted article to ISPE Pharmaceutical Engineering journal (2026): "Implementing Computer Software Assurance in Established Pharmaceutical Manufacturing: A Risk-Critical Transition Framework for Sites with Existing CSV Programs."
Use this About Nam Pham page as a planning checkpoint before vendor selection, architecture review, validation scoping or implementation sequencing. The strongest next step is to compare the guidance with your current SOPs, system inventory, batch records, data flows and QA review routines so the discussion starts from evidence instead of assumptions.
For About Nam Pham, prepare the records, owners, risks and decision criteria linked to professional background, philosophy, geographic and industry focus, memberships and recognition. Useful evidence includes current process maps, interface lists, audit trail expectations, exception workflows, data retention rules and the business reason for changing the current operating model.
Pharmaceutical automation and validation engineering — specifically GMP computerized systems, CSV/CSA transition programs, ALCOA+ data integrity, and ISA-95 architecture for pharmaceutical manufacturers in Vietnam and Southeast Asia.
11+ years (2015 to present) of hands-on experience in GxP manufacturing systems, validation programs, and OT/IT integration for pharmaceutical manufacturers in the APAC region.
ISPE (International Society for Pharmaceutical Engineering) and ISA (International Society of Automation).
English-language technical articles are on /blog. Vietnamese knowledge hub at phamducphuongnam.com. A full publications list is at /about/publications.